🇺🇸 FDA - Updated information on recommended AI for NDSRIs (23/Feb/2024) - Tables 2 & 3

According to the article, duloxetine capsules were recalled at a retail level.
This recall was initiated due to the presence of N-nitroso-duloxetine above the interim limit.

Duloxetine capsules distributed by Breckenridge Pharmaceutical, Inc. have been recalled

2 Likes